Who
Halley E. Gilbert
Director
Company insider
Files Form 4 as: Director, CytomX Therapeutics; Director, Vaxcyte; Director, Arcutis Biotherapeutics; Chief Legal Officer, NeoGenomics; Chief Admin Officer & SVP, Ironwood Pharmaceuticals; Director, Dermira; Director, Achaogen.
In numbers
- Trades disclosed
- 123
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $5.7M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 16 Mar 2015
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | CTMX CytomX Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —59,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CTMX CytomX Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —59,000 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,265 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,389 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,389 at $0.00 | filing |
| 15 Jun 2026filed 16 Jun 2026 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,265 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —5,778 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ARQT Arcutis Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,667 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ARQT Arcutis Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,667 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —5,778 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | ARQT Arcutis Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,220 at $0.00 | filing |
| 20 Nov 2025filed 21 Nov 2025 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Code M | $92K12,220 at $7.51 | filing |
| 20 Nov 2025filed 21 Nov 2025 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $455K16,532 at $27.55 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,372 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —3,041 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | ARQT Arcutis Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,568 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —7,609 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | CTMX CytomX Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | ARQT Arcutis Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,052 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | ARQT Arcutis BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —10,139 at $0.00 | filing |
News
Financial Review: Arcutis Biotherapeutics (NASDAQ:ARQT) and Iterum Therapeutics (NASDAQ:ITRM)ARQT · themarketsdaily.com · 6 Oct 2026
0 headlines in the last 90 days name Halley E. Gilbert; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.